Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 16, 2011Completed
Hide Studies Not Open or Pending
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 16, 2011Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 18, 2020Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 12, 2013Unknown status
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:January 18, 2018Terminated
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 18, 2013Unknown status
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:August 20, 2019Terminated
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 23, 2020Terminated
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 16, 2011Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 16, 2011Completed
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 16, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.